Works matching IS 10837159 AND DT 2020 AND VI 25 AND IP 5
Results: 33
Exploring Ways to Improve Access to and Minimize Risk from Lung Cancer Screening.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. 364, doi. 10.1634/theoncologist.2020-0149
- By:
- Publication type:
- Article
Completing the Translation.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
A Prospective Study of Apatinib in Patients with Extensive‐Stage Small Cell Lung Cancer After Failure of Two or More Lines of Chemotherapy.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. e833, doi. 10.1634/theoncologist.2019-0391
- By:
- Publication type:
- Article
Sarcopenia and Inflammation with Immunotherapy.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. e875, doi. 10.1634/theoncologist.2019-1005
- By:
- Publication type:
- Article
In Reply.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. e876, doi. 10.1634/theoncologist.2020-0059
- By:
- Publication type:
- Article
Impact on Health‐Related Quality of Life of Parenteral Nutrition for Patients with Advanced Cancer Cachexia: Results from a Randomized Controlled Trial.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. e843, doi. 10.1634/theoncologist.2019-0856
- By:
- Publication type:
- Article
High‐Grade Gastrointestinal Neuroendocrine Carcinoma Management and Outcomes: A National Cancer Database Study.
- Published in:
- 2020
- By:
- Publication type:
- Correction Notice
Late‐Onset Immunotherapy Toxicity and Delayed Autoantibody Changes: Checkpoint Inhibitor–Induced Raynaud's‐Like Phenomenon.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. e753, doi. 10.1634/theoncologist.2019-0666
- By:
- Publication type:
- Article
Renaissance of Radiotherapy in Intestinal Lymphoma? 10‐Year Efficacy and Tolerance in Multimodal Treatment of 134 Patients: Follow‐up of Two German Multicenter Consecutive Prospective Phase II Trials.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. e816, doi. 10.1634/theoncologist.2019-0783
- By:
- Publication type:
- Article
Inclusive Cancer Care: Rethinking Patients Living with HIV and Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. 361, doi. 10.1634/theoncologist.2019-0853
- By:
- Publication type:
- Article
Effectiveness of Olaparib Treatment in a Patient with Gallbladder Cancer with an ATM‐Inactivating Mutation.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. 375, doi. 10.1634/theoncologist.2019-0498
- By:
- Publication type:
- Article
Maximizing Breast Cancer Therapy with Awareness of Potential Treatment‐Related Blood Disorders.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. 391, doi. 10.1634/theoncologist.2019-0099
- By:
- Publication type:
- Article
Etiology and Prognosis of Pneumonia in Patients with Solid Tumors: A Prospective Cohort of Hospitalized Cases.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. e861, doi. 10.1634/theoncologist.2019-0031
- By:
- Publication type:
- Article
Exercise Intolerance in Anthracycline‐Treated Breast Cancer Survivors: The Role of Skeletal Muscle Bioenergetics, Oxygenation, and Composition.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. e852, doi. 10.1634/theoncologist.2019-0777
- By:
- Publication type:
- Article
Hypertrophic Lichen Planus with Histological Features of Squamous Cell Carcinoma Associated with Immune Checkpoint Blockade Therapy.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. 366, doi. 10.1634/theoncologist.2019-0796
- By:
- Publication type:
- Article
The Impact of Anlotinib on Brain Metastases of Non‐Small Cell Lung Cancer: Post Hoc Analysis of a Phase III Randomized Control Trial (ALTER0303).
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. e870, doi. 10.1634/theoncologist.2019-0838
- By:
- Publication type:
- Article
Managing Hyperprogressive Disease in the Era of Programmed Cell Death Protein 1/Programmed Death‐Ligand 1 Blockade: A Case Discussion and Review of the Literature.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. 369, doi. 10.1634/theoncologist.2019-0671
- By:
- Publication type:
- Article
Real‐World Assessment of Clinical Outcomes Among First‐Line Sunitinib Patients with Clear Cell Metastatic Renal Cell Carcinoma (mRCC) by the International mRCC Database Consortium Risk Group.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. 422, doi. 10.1634/theoncologist.2019-0605
- By:
- Publication type:
- Article
Anti‐PD1‐Induced Immune‐Related Adverse Events and Survival Outcomes in Advanced Melanoma.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. 438, doi. 10.1634/theoncologist.2019-0674
- By:
- Publication type:
- Article
A Pilot Feasibility Study of Yttrium‐90 Liver Radioembolization Followed by Durvalumab and Tremelimumab in Patients with Microsatellite Stable Colorectal Cancer Liver Metastases.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. 382, doi. 10.1634/theoncologist.2019-0924
- By:
- Publication type:
- Article
Molecular Analyses of Left‐ and Right‐Sided Tumors in Adolescents and Young Adults with Colorectal Cancer.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. 404, doi. 10.1634/theoncologist.2019-0552
- By:
- Publication type:
- Article
Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5‐Fluorouracil, and Leucovorin Versus Oxaliplatin, 5‐Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG‐ACRIN Research Group (E5204)
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. e798, doi. 10.1634/theoncologist.2019-0437
- By:
- Publication type:
- Article
An Open‐Label, Single‐Arm, Two‐Stage, Multicenter, Phase II Study to Evaluate the Efficacy of TLC388 and Genomic Analysis for Poorly Differentiated Neuroendocrine Carcinomas.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. e782, doi. 10.1634/theoncologist.2019-0490
- By:
- Publication type:
- Article
Incorporating Patient‐Reported Outcome Measures into Breast Surgical Oncology: Advancing Toward Value‐Based Care.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. 384, doi. 10.1634/theoncologist.2019-0355
- By:
- Publication type:
- Article
Real‐World Evidence in Oncology: Opportunities and Limitations.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. e746, doi. 10.1634/theoncologist.2019-0647
- By:
- Publication type:
- Article
Integrated, Multidisciplinary Management of Pulmonary Nodules Can Streamline Care and Improve Adherence to Recommendations.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. 431, doi. 10.1634/theoncologist.2019-0519
- By:
- Publication type:
- Article
Phase II Trial of Trifluridine/Tipiracil in Patients with Advanced, Refractory Biliary Tract Carcinoma.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. 380, doi. 10.1634/theoncologist.2019-0874
- By:
- Publication type:
- Article
Initial Results from Mobile Low‐Dose Computerized Tomographic Lung Cancer Screening Unit: Improved Outcomes for Underserved Populations.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. e777, doi. 10.1634/theoncologist.2019-0802
- By:
- Publication type:
- Article
Blood‐Based Next‐Generation Sequencing Analysis of Appendiceal Cancers.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. 414, doi. 10.1634/theoncologist.2019-0558
- By:
- Publication type:
- Article
Extended Survival After Surgical Resection for Pituitary Metastases: Clinical Features, Management, and Outcomes of Metastatic Disease to the Sella.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. e789, doi. 10.1634/theoncologist.2019-0520
- By:
- Publication type:
- Article
A Multidisciplinary Head‐to‐Head Comparison of American College of Radiology Thyroid Imaging and Reporting Data System and American Thyroid Association Ultrasound Risk Stratification Systems.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. 398, doi. 10.1634/theoncologist.2019-0362
- By:
- Publication type:
- Article
Ipilimumab and Gemcitabine for Advanced Pancreatic Cancer: A Phase Ib Study.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. e808, doi. 10.1634/theoncologist.2019-0473
- By:
- Publication type:
- Article
Brain Metastases from Biliary Tract Cancers: A Case Series and Review of the Literature in the Genomic Era.
- Published in:
- Oncologist, 2020, v. 25, n. 5, p. 447, doi. 10.1634/theoncologist.2019-0306
- By:
- Publication type:
- Article